MedPath

Oglemilast

Generic Name
Oglemilast
Drug Type
Small Molecule
Chemical Formula
C20H13Cl2F2N3O5S
CAS Number
778576-62-8
Unique Ingredient Identifier
67GXQ6WCC6

Overview

Oglemilast has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive.

Background

Oglemilast has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma
Phase 2
Posted: 2009/03/11
Sponsor:
Glenmark Pharmaceuti...
ID:NCT00859404
Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Phase 2
Completed
Posted: 2008/05/02
Sponsor:
Forest Laboratories
ID:NCT00671073
Study of Oglemilast for the Treatment of Asthma
Phase 2
Completed
Posted: 2006/05/08
Sponsor:
Forest Laboratories
ID:NCT00322686
Study of Oglemilast for the Prevention of Asthma.
Phase 2
Completed
Posted: 2006/05/05
Sponsor:
Forest Laboratories
ID:NCT00322283

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy